The Role of Fiber in the Treatment of Irritable Bowel Syndrome: Therapeutic Recommendations
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome is a common clinical condition that often presents a therapeutic challenge. There is no standard therapy and a multilevel approach is recommended. A high-fiber diet is often one of these components. Many investigators have studied the effectiveness of either fiber supplementation or bulking agents in patients with irritable bowel syndrome. The purpose of this review is to summarize the current literature on the use of fiber in irritable bowel syndrome and to provide some specific recommendations. Systematic reviews of these trials have generally not found fiber to be significantly more effective than placebo at relieving global irritable bowel syndrome symptoms. There may be differences between results obtained with soluble and insoluble fiber. Adverse effects of fiber use may include abdominal discomfort and bloating. Although dietary fiber or bulking agents do not appear to be useful as sole treatment of irritable bowel syndrome, they may have a limited role in empiric therapy depending upon the patient's symptom complex, especially if constipation is the most significant symptom. The basic principles for using fiber therapy are to start with a low dose and increase slowly, to give an adequate trial and to evaluate the results early and periodically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
Hungin, A. P. S., Chang, L., Locke, G. R., Dennis, E. H., & Barghout, V. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02463.x · Cited by 494 · cited 3×
“A recent large community survey in the United States found an IBS prevalence of 14.1%, with IBS-type frequency being 12.7% for IBS-C, 21.3% for IBS-D, and 66.0% for IBS-A.6 Although only a minority of those with IBS symptoms in the United States seek health care, and a variable percentage in other countries,2 IBS is c…”
BackgroundInfluentialIrritable bowel syndrome in general practice: prevalence, characteristics, and referral
Thompson, W. G., Heaton, K. W., Smyth, G. T., & Smyth, C. (2000) · Gut · doi:10.1136/gut.46.1.78 · Cited by 477 · cited 1×
“Fiber and bulking agents are often prescribed by physicians.(15,17) Clinicians may also make dietary recommendations for treatment of diarrhea and abdominal pain or bloating.”
BackgroundQuartero, A. O., Meiniche-Schmidt, V., Muris, J., Rubin, G., & de Wit, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub2 · Cited by 190
Bowel Habit Subtypes and Temporal Patterns in Irritable Bowel Syndrome: Systematic Review
Guilera, M., Balboa, A., & Mearin, F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40674.x · Cited by 131
Use of Diet and Probiotic Therapy in the Irritable Bowel Syndrome: Analysis of the Literature
Floch, M. H. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000156104.67505.5b · Cited by 52
Cited by
Fiber and Functional Gastrointestinal Disorders
Eswaran, S., Muir, J., & Chey, W. D. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.63 · Cited by 436
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Gastrointestinal Effects of Low-Digestible Carbohydrates
Grabitske, H. A., & Slavin, J. L. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802067126 · Cited by 267
Irritable bowel syndrome: A clinical review
Soares, R. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12144 · Cited by 266
Complementary and alternative medicine for treatment of irritable bowel syndrome.
(2009) · PubMed Central · Cited by 89
Metadata
- Authors
- Zuckerman, M. J.
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2006-02
- Volume
- 40
- Issue
- 2
- Pages
- 104-108
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W1979220925
- Cited by
- 43
- References
- 7
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Fiber in the Treatment of Irritable Bowel Syndrome: Therapeutic Recommendations. https://app.cochat.ai/papers/10.1097/01.mcg.0000196405.15110.bb
- The paper
- Zuckerman, M. J. (2006). The Role of Fiber in the Treatment of Irritable Bowel Syndrome: Therapeutic Recommendations. Journal of Clinical Gastroenterology. https://doi.org/10.1097/01.mcg.0000196405.15110.bb
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.